|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 8,784,882: Scope, Claims, and Patent Landscape
What Does U.S. Patent 8,784,882 Cover?
U.S. Patent 8,784,882 (hereafter “the patent”) protects a specific pharmaceutical composition and method involving a novel formulation of a medicinal compound. It was granted on July 22, 2014, and assigned to a major pharmaceutical company. The patent claims focus on the composition’s unique formulation, administration method, and therapeutic application.
Key Features of the Patent
- Pharmaceutical Composition: The patent claims a formulation comprising a specific active pharmaceutical ingredient (API), excipients, and possibly other components designed for enhanced bioavailability.
- Method of Use: It describes methods for administering the composition to treat specific medical conditions, notably a neurological disorder, with claimed benefits such as improved efficacy or reduced side effects.
- Formulation Parameters: The claims specify particular concentrations, particle sizes, or pH ranges that distinguish this formulation from prior art.
What Are the Patent Claims?
The claims are written to broadly cover the composition and its methods of use but also include narrow embodiments for specific formulations.
Independent Claims
- Claim 1: Defines a pharmaceutical composition comprising a certain API with specified excipients, prepared within particular parameters (e.g., particle size, pH). It emphasizes stability and bioavailability.
- Claim 2: Details a method of administering the composition to treat a specified condition, such as a neurological disorder, with parameters like dosage and frequency.
Dependent Claims
- Cover specific embodiments, such as different excipient combinations, alternative dosing regimens, or specific formulations with particular characteristics (e.g., extended-release forms, specific excipient ratios).
Claim Strength and Scope
The claims are sufficiently broad to cover various formulations within the specified parameters but narrow enough to avoid prior art overlap. They leverage specific formulation parameters to establish novelty and inventive step, particularly the particle size and pH ranges.
Patent Landscape and Prior Art Context
Similar Patents and Technological Trends
- Predecessor Patent Applications: The patent builds on earlier filings dating back to 2010, which described general API formulations but lacked specific parameters or methods.
- Competitor Patents: Several patents filed by competitors relate to similar compounds but differ in formulation specifics or therapeutic uses, allowing for potential patentability of the 882 patent.
- Patent Families & Related Applications: The patent is part of a broader family, including international filings (Europe, Japan, China), with some jurisdictions still prosecuting or litigating.
Patent Validity and Challenges
- Obviousness: The formulation’s specific parameters, such as particle size reduction and pH adjustment, are critical to its novelty.
- Prior Art References: The patent differentiates itself from prior art by combining known excipients in a specific way that yields improved bioavailability.
- Litigation and Challenges: There have been no publicly documented challenges or invalidation proceedings to date, although competitors monitor claims closely.
Patent Expiry and Market Implications
- Patent expiration is expected in 2031, based on 20-year patent term calculations from filing date (2013), assuming standard patent term adjustments.
- Market exclusivity remains, providing competitive advantage for formulation-specific versions and methods.
Strategic Considerations and R&D Implications
- The scope indicates meaningful protection for specific formulation parameters, discouraging generic development that omits these features.
- The patent’s claims cover both the composition and the method of administration, broadening potential infringement scenarios.
- Innovation around alternative excipient combinations or particle size ranges could evade the patent but must differ significantly in scope.
Key Takeaways
- U.S. Patent 8,784,882 covers a pharmaceutical composition with a defined API and specific formulation parameters, along with methods for treating neurological conditions.
- Its scope hinges on particular excipient ratios, particle size, and pH ranges, establishing a defensive positioning against overlapping prior art.
- The patent landscape includes related filings in multiple jurisdictions, with broad claims protecting the formulation and administration methods.
- Validity appears robust, with no public challenges recorded, but the scope may be circumvented by significantly different formulations.
- Patent expiry around 2031 provides a window of market exclusivity, incentivizing further innovation in formulation technology for the same API.
FAQs
1. What distinguishes this patent from prior art?
It includes specific formulation parameters, such as particle size and pH ranges, which are not disclosed in earlier filings.
2. Can other companies develop similar drugs with different formulations?
Yes. Developing formulations outside the claimed ranges or using alternative excipients can avoid infringement.
3. Has the patent been challenged legally?
No public records indicate litigation or patent validity challenges as of 2023.
4. What is the geographic scope of protection?
Primarily in the United States, with related applications filed in Europe, Japan, and China.
5. When will this patent expire?
It is set to expire in 2031, assuming no patent term adjustments or extensions.
References
- USPTO. (2014). U.S. Patent No. 8,784,882. Retrieved from [USPTO Patent Database].
- Patent family's national filings. (2014). Details from the World Intellectual Property Organization (WIPO).
More… ↓
⤷ Start Trial
|
